Mechanistically, miR-197-mediated PPARG downregulation reduces E-cadherin levels while upregulating mesenchymal markers like Vimentin, collectively enhancing tumor cell invasiveness and hepatic metastasis [49]. This evidence concerns the gene CDH1 and neoplasm.